Full Text View
Tabular View
Study Results
Related Studies
Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy
This study has been completed.
Study NCT00293020   Information provided by BioDelivery Sciences International

First Received on February 15, 2006.   Last Updated on September 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain
Cancer
Interventions listed in this trial
BEMA Fentanyl
Additional drug interventions recognized in this trial
Analgesics, Opioid
Fentanyl
More general drug interventions related to this trial
Adjuvants, Anesthesia
Analgesics
Anesthetics
Anesthetics, General
Anesthetics, Intravenous
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
BioDelivery Sciences International


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services